Sanofi-Aventis Dealt A Setback
By Ron Zapata ( February 9, 2007, 12:00 AM EST) -- Sanofi-Aventis was dealt a blow in its attempt to prevent a generic version of its popular anti-clotting drug Lovenox when a U.S. District Court judge ruled that the drug maker was deceptive when it applied for the patent for the drug....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.